| Q34045764 | A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia |
| Q33654165 | Anxiety and stigma in dementia: a threat to aging in place |
| Q48255525 | Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial |
| Q34661845 | Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience |
| Q34000911 | Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia |